7.10
Bioventus Inc Azioni (BVS) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-28 | 2025-03-29 | 2024-12-31 | 2024-09-28 | 2024-06-29 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
19.20%
147.66
|
123.88 | 153.64 | 138.96 | 151.22 |
Cost Of Revenue |
11.64%
45.57
|
40.82 | 50.99 | 45.41 | 47.58 |
Gross Profit |
22.92%
102.09
|
83.06 | 102.66 | 93.55 | 103.64 |
|
7.08%
83.72
|
78.19 | 94.67 | 89.48 | 133.01 |
Benefits Costs and Expenses |
7.90%
137.35
|
127.29 | 153.41 | 143.80 | 190.67 |
Costs And Expenses |
7.90%
137.35
|
127.29 | 153.41 | 143.80 | 190.67 |
Depreciation and Amortization |
9.67%
1.439
|
1.593 | 1.768 | 2.065 | 2.064 |
Operating Income/Loss |
277.24%
18.37
|
4.869 | 7.988 | 4.074 | -29.37 |
Nonoperating Income/Loss |
2.79%
-8.055
|
-8.286 | -7.756 | -8.906 | -10.08 |
Income/Loss From Continuing Operations Before Tax |
401.81%
10.31
|
-3.417 | 0.232 | -4.832 | -39.45 |
Income Tax Expense/Benefit |
1,196%
1.041
|
-0.095 | 0.55 | 0.589 | -7.339 |
Income/Loss From Continuing Operations After Tax |
379.11%
9.272
|
-3.322 | -0.318 | -5.421 | -32.11 |
|
379.11%
9.272
|
-3.322 | -0.318 | -5.421 | -32.11 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
364.67%
1.813
|
-0.685 | -0.162 | -0.597 | -8.12 |
Basic Average Shares |
0.74%
66.50
|
66.01 | 0.3126 | 65.26 | 64.06 |
Diluted Average Shares |
3.83%
68.54
|
66.01 | 0.3126 | 65.26 | 64.06 |
Basic Earnings Per Share |
375.00%
0.11
|
-0.04 | - | -0.07 | -0.37 |
Diluted Earnings Per Share |
375.00%
0.11
|
-0.04 | - | -0.07 | -0.37 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):